key: cord-0897302-geodq1et authors: Giver, Jean; Dunn, Amy L.; Sankar, Amanda; Stanek, Joseph; Monda, Kay; Canini, Joan; Kerlin, Bryce A.; Rodriguez, Vilmarie title: Drive-through Anticoagulation Clinic During The COVID-19 Pandemic date: 2021-09-08 journal: J Nurse Pract DOI: 10.1016/j.nurpra.2021.08.026 sha: 4422b329293ef42c0603deb6d66f21994c3ca61d doc_id: 897302 cord_uid: geodq1et An innovative approach to anticoagulation management during the COVID-19 pandemic was used at our center that allowed patients to stay in their vehicle while our anticoagulation advanced practice nurse obtained blood for point-of-care INR (POC/INR) testing, while at the same time, education and counseling were completed. A significant improvement in the median percentage of INR within the therapeutic range (TR) was observed among the patients who utilized the drive-through clinic. A small group of patients improved compliance to anticoagulation monitoring. Clinical care models, such as this clinic approach may improve patient compliance and adherence to anticoagulation beyond the pandemic needs. • COVID-19 pandemic created barriers for medical providers and patients, leading medical institutions to implement innovative approaches to provide safe care to patients while at the same time being compliant with health organizations' recommendations to prevent exposure to the virus. • A drive-through anticoagulation clinic can have a positive impact on compliance and quality of anticoagulation care. • COVID-19 pandemic created barriers for medical providers and patients, leading medical institutions to implement innovative approaches to provide safe care to patients while at the same time being compliant with health organizations' recommendations to prevent exposure to the virus. • A drive-through anticoagulation clinic can have a positive impact on compliance and quality of anticoagulation care. 1 1 2 Abstract: 3 An innovative approach to anticoagulation management during the COVID-19 pandemic was 4 used at our center that allowed patients to stay in their vehicle while our anticoagulation 5 advanced practice registered nurse obtained blood for point-of-care INR (POC/INR) testing, 6 while at the same time, education and counseling were completed. A significant improvement 7 in the median percentage of INR within the therapeutic range (TR) was observed among the 8 patients who utilized the drive-through clinic. A small group of patients improved compliance to 9 anticoagulation monitoring. Clinical care models, such as this clinic approach may improve 10 patient compliance and adherence to anticoagulation beyond the pandemic needs. Introduction: 14 Given the rapid spread of the SARS-CoV-2 virus , further referred to as the COVID-19 virus, and 15 its detrimental effects on global health, the World Health Organization (WHO) declared the 16 COVID-19 outbreak a global pandemic on March 11, 2020. 1 The highly contagious nature of this 17 virus has created major challenges for the medical care of patients. Patients with pre-existing 18 chronic health conditions, such as cardiovascular diseases, have a higher risk for severe COVID- 19 19 infection. 2 the concept and experience of using a drive-through clinic for anticoagulation monitoring and 31 management. [8] [9] [10] [11] There are limited data on how this model of care can impact anticoagulation (Table 2 ). Our study is perhaps, one of the few that 156 documented patients' outcomes with this care model (Table 3) . Other programs had 157 implemented a similar approach in larger anticoagulation programs and/or satellite clinics 158 however their analyses are primarily patient satisfaction and improved access to care. 159 There are several limitations with our model of care and this report. First, we were only able to 160 provide this option of care to families with vehicles who lived close to our medical center and 161 were willing to come as a drive-through appointment. We lacked the staff resources to provide The medical staff showed concern for myself and/or my Cardiovascular considerations for patients, health 190 care workers, and health systems during the coronavirus disease COVID-19 and thrombotic or thromboembolic 194 disease: implications for prevention, antithrombotic therapy, and follow up Anticoagulation Forum: Managing Anticoagulation During Management of outpatient warfarin therapy 205 amid COVID-19 pandemic: A practical guide Managing anticoagulation in the COVID-19 era between 208 lockdown and reopening phases Thromboembolism and anticoagulation therapy during 211 COVID-19 pandemic: Interim clinical guidelines from the anticoagulation forum During the COVID-19 Pandemic Anticoagulation clinic drive-up 224 service during COVID-19 pandemic in Qatar Ohio Department of Health COVID-19 Oral anticoagulant therapy: practical aspects of management Anticoagulation clinics for children achieve 233 improved warfarin management Assessing outcome measures of oral 236 anticoagulation management in children Time in therapeutic range as a marker for 239 thrombotic and bleeding outcomes in Fontan patients Utility of a Dedicated Pediatric Cardiac 242 Anticoagulation Program: The Boston Children's Hospital Experience • Anticoagulation clinics have improved bleeding and thrombosis outcomes via education and close surveillance of anticoagulation therapy.• COVID-19 pandemic created barriers for medical providers and patients, leading medical institutions to implement innovative approaches to provide safe care to patients while at the same time being compliant with health organizations' recommendations to prevent exposure to the virus.• A drive-through anticoagulation clinic can have a positive impact on compliance and quality of anticoagulation care.